Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 48.18 billion as of September 29, 2025. Its market cap has increased by 12.14% in one year.

Market Cap

48.18B

Enterprise Value

47.18B

Revenue

37.25M

Ranking

n/a

PE Ratio

n/a

Stock Price

286.00

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 48.18B, an increase of 1,021.80%. That is a compound annual growth rate of 26.73%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	48.18B	14.11%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	286.16B
PharmaEssentia	189.36B
Bora Pharmaceuticals Co., LTD.	84.40B
Lotus Pharmaceutical	67.06B
Oneness Biotech	32.14B
Polaris Group	28.58B
Center Laboratories	27.60B
Pegavision	24.57B

Market Cap Rankings